88999-8
Omega-3 (EPA+DHA) index risk in Serum or Plasma
Active
Term Description
The omega-3 index, defined as eicosapentaenoate (EPA)+ docosahexaenoate (DHA)/Fatty acids.C14-C24, is a clinically useful measurement for evaluating blood levels of EPA and DHA. There are many health benefits from maintaining a good level of omega-3 fatty acids including reduced inflammation, risk of heart disease, cancer, arthritis, and many more. Deficiency in omega-3 fatty acids can result in fatigue, poor memory, dry skin, heart problems, mood swings, and poor circulation.[https://www.umm.edu/health/medical/altmed/supplement/omega3-fatty-acids] There have been a number of clinical trials to determine the effect of omega-3 supplementation based on a 1g/day dose of EPA, which successfully increased the total omega-3 level to >5% for 84% of the study participants. The remaining 16% had levels below 5%, which is the threshold at which significant reduction in sudden coronary death reduction is evident. The variability in the blood levels of omega-3 in patients who received the same supplemental dose of omega-3 has been attributed to genetic differences in fatty acid metabolism, body weight, baseline omega-3 level, age, gender, and physical activity. PMID: 25285179 This test measures the level of omega-3 as a percent of total fatty acids, and the result of that index is associated with a high, moderate, or low risk of cardiovascular disease.
Source: Regenstrief LOINC
Part Descriptions
LP266157-9 Eicosapentaenoate+Docosahexaenoate
Eicosapentaenoate (EPA) is a long chain omega-3 fatty acid that is present throughout the body including in cell membranes. EPA is found in fatty fish including salmon, tuna, mackerel, sardines, shellfish, and herring. EPA can be biosynthesized from alpha-linolenic acid (ALA), but it is much more efficient to increase levels by including EPA-rich sources in one's diet. EPA has anti-inflammatory properties that are vital to fetal development and the process of healthy aging. Its anti-inflammatory effects are due to reduced gene expression of genes involved in inflammatory and atherogenesis-related pathways, thereby lowering the risk of cardiovascular disease. EPA has also been found to increase platelet stability, decrease endothelial activation, and improve vascular permeability. Taking EPA supplements leads to an increased amount of EPA in the plaque of carotid arteries which may decrease inflammation and increase plaque stability. PMID: 22332096 Many other studies have been run that show acorrelation between higher plasma levels of EPA and reduced symptoms of disease, some of which include Alzheimer's disease, depression, rheumatoid arthritis, and Raynaud Syndrome.[ http://pennstatehershey.adam.com/content.aspx?productId=107&pid=33&gid=000301]
Source: Regenstrief LOINC
LP266157-9 Eicosapentaenoate+Docosahexaenoate
Docosahexaenoate (DHA) is one of the essential polyunsaturated omega-3 fatty acids that is primarily obtained by ingesting fatty fish including salmon, mackerel, tuna, herring, and sardines.[https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/] There are many benefits derived from eating healthy levels of DHA including a reduction of chronic inflammation, atherosclerosis, hypertension, arthritis, depression, adult-onset diabetes mellitus, myocardial infarction, thrombosis, and some cancers. DHA is important in brain development of infants and in maintaining normal brain function in adults. Studies have demonstrated that infants who drink DHA-fortified formula have higher visual acuity than infants who drink unfortified formula. Deficiencies of DHA have been associated with fetal alcohol syndrome, attention deficit hyperactivity disorder, cystic fibrosis, phenylketonuria, unipolar depression, aggressive hostility, adrenoleukodystrophy, cognitive decline in aging individuals, and the onset of sporadic Alzheimer's disease. Patients who consume 200 mg/day of DHA have a 50% reduction in the incidence of sudden cardiac arrest. PMID: 10479465
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Eicosapentaenoate+docosahexaenoate/Fatty acids.C14-C24 index risk
- Property
- Imp
- Time
- Pt
- System
- Ser/Plas
- Scale
- Ord
- Method
Additional Names
- Short Name
- Omega-3 index risk SFr SerPl
- Display Name
- EPA+DHA/Fatty acids.C14-C24 index risk Ql [Interp]
- Consumer Name Alpha Get Info
- EPA+DHA/Fatty Acids.C14-C24 Index Risk, Blood
Preferred Answer List: LL4892-7
Answer | Code | Score | Answer ID |
---|---|---|---|
Index <2.2: High risk of cardiovascular disease | LA28572-8 | ||
Index 2.2-3.2: Moderate risk of cardiovascular disease | LA28573-6 | ||
Index >3.2: Low risk of cardiovascular disease | LA28574-4 |
Basic Attributes
- Class
- CHEM
- Type
- Laboratory
- First Released
- Version 2.64
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 16335
Member of these Panels
LOINC | Long Common Name |
---|---|
88884-2 | Fatty acid omega-3 and omega-6 panel - Serum or Plasma |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Eicosapentaenoato + Docosahexaenoato/Indice de riesgo acidos grasos C14-C24: |
es-MX | Spanish (Mexico) | Eicosapentaenoato + docosahexaenoato / Ácidos grasos Índice de riesgo C14-C24: |
fr-FR | French (France) | Eicosapentaénoate+docosahexaénoate/acides gras C14-C24 facteur de risque: |
it-IT | Italian (Italy) | Eicosapentaenoato+Docosaesaenoato/Acidi grassi.C14-C24, fattore di rischio: Synonyms: Chimica Docosaesaenoato (C22: |
zh-CN | Chinese (China) | 二十碳五烯酸+二十二碳六烯酸/脂肪酸类.C14-C24 指数风险: Synonyms: C20: |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=88999-8
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright